FindTrial
Sign In

Side Effects in Chemotherapy Patients

A study on adverse effects induced by chemotherapy among cancer patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/10/059187
Enrollment
100
Registered
2023-10-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z511- Encounter for antineoplastic chemotherapy and immunotherapy

Interventions

Intervention1: NIL: NIL

Sponsors

Sumithra Devadiga
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing chemotherapy

Exclusion criteria

Exclusion criteria: •Patient known to be diabetics (Type 1 and/or Type 2) and were under medication for it. (Applicable for chemotherapy induced hyperglycemia) •Patient who discontinued the treatment.

Design outcomes

Primary

MeasureTime frame
Assessment of the ADRs associated with different types of chemotherapeutic drugs and its prevalence.Timepoint: Depends on chemotherapy cycle.—

Secondary

MeasureTime frame
Secondary outcome is improvement of quality of life of patients receiving chemotherapy through management of ADR in a timely manner.Timepoint: Depends on Chemotherapy cycle—

Countries

India

Contacts

Public ContactSuha Zulekha

Karavali College of Pharmacy

sajanfrancisp1998@gmail.com9496653086

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026